Eidogen-Sertanty Releases TIP/Kinase

San Diego, CA (Jan 22, 2009) – Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, today announced the release of TIP/Kinase - a database containing thousands of protein structures, co-complexes and models which survey the Human Kinome

Kinases continue to be hot targets within the pharmaceutical industry. Complementing Eidogen-Sertanty's Kinase Knowledgebase (KKB) which contains hundreds of thousands of structure-activity datapoints, TIP/Kinase provides protein structural and binding-site information which enables comparative analysis across the entire Kinome. TIP/Kinase includes structures, co-complexes, and multiple templated-models for over 500 human kinases and will self-proliferate with the addition of new protein structures and/or co-complexes using TIP's automated modeling capabilities.

With this promotional release TIP/Kinase, Eidogen-Sertanty is offering a special bundle which includes the TIP/Kinase database, a fully-functional behind-the-firewall release of TIP/Workgroup, and Kinase Knowledgebase structure-activity data exports.

For more information, please contact:

Steve Muskal
760-729-0211
pr@eidogen-sertanty.com

About Eidogen-Sertanty, Inc.
Eidogen-Sertanty, formed in March 2005 from the merger of Eidogen and Sertanty, is a privately held company providing pioneering knowledge-driven discovery solutions to biotechnology and pharmaceutical organizations.  Eidogen-Sertanty’s unique and powerful suite of software, databases, and drug discovery services enable customers and collaborators to apply a knowledge-driven discovery approach to a variety of workflows and processes, including target selection and prioritization, library building and compound prioritization, and lead design and optimization.  To find out more about Eidogen-Sertanty and their products and services please visit www.eidogen-sertanty.com.